When various biological agents relate to IgE, thymic stromal lymphopoietin (TSLP) and Th2 cytokines (IL-4, IL-5, IL-13) are added to intensive controller medications; these agents are somewhat effective for a subgroup of patients with severe asthma. This evidence concerns the gene IL13 and asthma.